Literature DB >> 14960679

Total knee arthroplasty in patients with liver cirrhosis.

Lih-Yuann Shih1, Chun-Ying Cheng, Chung-Hsun Chang, Kuo-Yao Hsu, Robert Wen-Wei Hsu, Hsin-Nung Shih.   

Abstract

BACKGROUND: Patients with liver cirrhosis have an increased risk of surgical morbidity and mortality. We are aware of no study that has investigated the risks and outcomes of elective orthopaedic procedures in these patients. The purposes of the present study were to review the results of total knee arthroplasty in patients with cirrhosis and to identify risk factors leading to poor results.
METHODS: Fifty-one patients with cirrhosis who had undergone sixty total knee arthroplasties for osteoarthritis were studied. The medical records and laboratory data were collected retrospectively. All data were compared with those for matched patients without cirrhosis. Forty-two patients (fifty-one knees) with complete follow-up were evaluated with regard to complications, mortality, and factors leading to poor results.
RESULTS: Total knee arthroplasty was associated with significantly more blood loss, a longer hospital stay, more complications, and a higher mortality rate in patients with cirrhosis as compared with control patients (p </= 0.006 for all). Twenty-six complications occurred in twenty patients (twenty-two knees). Logistic regression analysis showed that a history of hepatic decompensation or variceal bleeding was an independent predictor of complications. Infection was the most common complication (prevalence, 21%). Age, platelet count, and hepatitis-B-related cirrhosis were independent predictors of infection. There were no perioperative deaths. Fifteen patients died at a mean of forty-three months after total knee arthroplasty; two deaths were related to the procedure. The presence of a hepatoma was found to be a significant predictor of mortality (p < 0.001).
CONCLUSIONS: The rate of complications after total knee arthroplasty was significantly higher in patients with cirrhosis than in control patients (p < 0.001). We believe that total knee arthroplasty should not be performed in patients with a history of hepatic decompensation or variceal bleeding. The risk of infection was high in older patients, patients with a low platelet count, and patients in whom the cirrhosis was related to the hepatitis-B virus. Aggressive prophylaxis against infection should be performed. Patients with Child class-A cirrhosis without these risk factors may do well following a total knee arthroplasty. The benefit of total knee arthroplasty should be cautiously weighed against its potential risks in patients with cirrhosis.

Entities:  

Mesh:

Year:  2004        PMID: 14960679     DOI: 10.2106/00004623-200402000-00017

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  22 in total

1.  Renal and Gastrointestinal Considerations in Joint Replacement Surgery.

Authors:  Benjamin Voss; Alexander Kurdi; Alexander Skopec; Jasmine Saleh; Mouhanad M El-Othmani; Joseph M Lane; William M Mihalko; Khaled J Saleh
Journal:  J Nat Sci       Date:  2015-02-01

2.  Outcome analysis of hip or knee arthroplasty in patients with cirrhotic liver disease.

Authors:  Young-Jun Seol; Taek-Rim Yoon; Dong-Hyun Lee; Sun-Ho Lee; Kyung-Soon Park
Journal:  J Orthop       Date:  2017-01-04

3.  Central sensitization is a risk factor for wound complications after primary total knee arthroplasty.

Authors:  Man Soo Kim; In Jun Koh; Seung Yeol Lee; Yong In
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-24       Impact factor: 4.342

4.  Impact of Cirrhosis on Resource Use and Inpatient Complications in Patients Undergoing Total Knee and Hip Arthroplasty.

Authors:  Jared M Newman; Nicholas K Schiltz; Christopher D Mudd; Caleb R Szubski; Alison K Klika; Wael K Barsoum
Journal:  J Arthroplasty       Date:  2016-04-27       Impact factor: 4.757

5.  Increased rates of periprosthetic joint infection in patients with cirrhosis undergoing total joint arthroplasty.

Authors:  Shirley L Jiang; William W Schairer; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2014-04-08       Impact factor: 4.176

6.  Equal 3-Year Outcomes for Kidney Transplantation Alone in HCV-Positive Patients With Cirrhosis.

Authors:  Afshin Parsikia; Stalin Campos; Kamran Khanmoradi; John Pang; Manjula Balasubramanian; Radi Zaki; Jorge Ortiz
Journal:  Int Surg       Date:  2015-01

7.  Increased complication rates after hip and knee arthroplasty in patients with cirrhosis of the liver.

Authors:  John V Tiberi; Viktor Hansen; Naglaa El-Abbadi; Hany Bedair
Journal:  Clin Orthop Relat Res       Date:  2014-07-04       Impact factor: 4.176

Review 8.  Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.

Authors:  Farida Millwala; Geoffrey C Nguyen; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

9.  What is the success of treatment of hip and knee candidal periprosthetic joint infection?

Authors:  Steve W N Ueng; Ching-Yu Lee; Chih-chien Hu; Pang-Hsin Hsieh; Yuhan Chang
Journal:  Clin Orthop Relat Res       Date:  2013-04-30       Impact factor: 4.176

10.  Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty.

Authors:  Joshua S Everhart; Eric Altneu; Jason H Calhoun
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.